VACCITECH (SP.ADR)/1 (2AB) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.051x

Based on the latest financial reports, VACCITECH (SP.ADR)/1 (2AB) has a cash flow conversion efficiency ratio of -0.051x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-3.37 Million ≈ $-3.94 Million USD) by net assets (€66.48 Million ≈ $77.72 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 2AB market cap for the company's overall valuation and market capitalisation.

VACCITECH (SP.ADR)/1 - Cash Flow Conversion Efficiency Trend (2021–2025)

This chart illustrates how VACCITECH (SP.ADR)/1's cash flow conversion efficiency has evolved over time, based on yearly financial data.

VACCITECH (SP.ADR)/1 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of VACCITECH (SP.ADR)/1 ranked by their cash flow conversion efficiency. Explore cash flow quality index of VACCITECH (SP.ADR)/1 to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Pure Hydrogen Corporation Ltd AU:PH2	-0.252x
Gensight Biologics SA PA:SIGHT	0.260x
Bankers Investment Trust LSE:BNKR	0.029x
Rex Industry Bhd KLSE:9946	0.424x
First Hydrogen Corp V:FHYD	0.122x
Resonance Health Ltd AU:RHT	0.016x
Metavista3D Inc. V:DDD	N/A
Phol Dhanya Public Company Limited BK:PHOL	0.109x

Annual Cash Flow Conversion Efficiency for VACCITECH (SP.ADR)/1 (2021–2025)

The table below shows the annual cash flow conversion efficiency of VACCITECH (SP.ADR)/1 from 2021 to 2025. View 2AB stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€74.29 Million ≈ $86.86 Million	€-47.98 Million ≈ $-56.09 Million	-0.646x	-190.41%
2024-12-31	€130.13 Million ≈ $152.14 Million	€-28.94 Million ≈ $-33.83 Million	-0.222x	+18.34%
2023-12-31	€187.00 Million ≈ $218.62 Million	€-50.92 Million ≈ $-59.54 Million	-0.272x	-358.95%
2022-12-31	€243.20 Million ≈ $284.33 Million	€-14.43 Million ≈ $-16.87 Million	-0.059x	+54.01%
2021-12-31	€252.56 Million ≈ $295.27 Million	€-32.58 Million ≈ $-38.09 Million	-0.129x	--

About VACCITECH (SP.ADR)/1

F:2AB Germany Biotechnology

Market Cap

$24.11 Million

€20.62 Million EUR

Market Cap Rank

#25107 Global

#2152 in Germany

Share Price

€0.51

Change (1 day)

+5.65%

52-Week Range

€0.45 - €1.54

All Time High

€14.00